Fidelity Mid Cap Index Fund Outperforms Benchmark in Q4 2025
In the final quarter of 2025, the Fidelity Mid Cap Index Fund (FSMDX) demonstrated a performance consistent with its benchmark, the Russell Midcap® Index. The fund's ability to align with the index's 0.16% growth was notably bolstered by income generated from security lending and strategic adjustments made to account for specific benchmark securities that the fund is precluded from acquiring. The broader index's gains were primarily driven by the robust showing of the defensive-oriented healthcare sector, particularly its strong performance in November. This outcome underscores the fund's commitment to mirroring its benchmark's returns while actively managing its portfolio to mitigate tracking error.
Fidelity Mid Cap Index Fund Achieves Benchmark Alignment in Fourth Quarter 2025
In the concluding quarter of 2025, the Fidelity Mid Cap Index Fund (FSMDX) successfully matched the performance of its benchmark, the Russell Midcap® Index, recording a 0.16% gain. Fidelity Investments, the fund's manager, confirmed that two primary factors significantly contributed to this strong alignment: substantial income derived from security lending activities and strategic adjustments for certain benchmark securities that the fund's mandate restricts it from holding. These deliberate portfolio modifications enabled the fund to maintain close correlation with the index's movements. The overall performance of the Russell Midcap® Index during this period was largely propelled by the defensive healthcare sector, which experienced a particularly impressive surge in November, contributing to the index's narrow but positive advance. Furthermore, Fidelity highlighted its ongoing commitment to minimizing tracking error, a crucial metric that measures the volatility of return differences over time, ensuring the fund's returns consistently reflect those of its benchmark.
This quarter's results offer valuable insights into effective index fund management. The Fidelity Mid Cap Index Fund's success in mirroring its benchmark, even with specific investment restrictions, demonstrates the importance of strategic portfolio adjustments and the benefit of ancillary income streams like security lending. For investors, this performance reaffirms the fund's ability to provide broad market exposure to mid-capitalization companies with a low tracking error, making it a reliable option for those seeking passive investment strategies in the mid-cap segment. The strong performance of the healthcare sector also underscores its role as a defensive asset in a fluctuating market, offering stability and growth even amidst broader market shifts.